Dr. Sledge reflects on one of the most historic moments in oncology: the first drug ever approved to treat pancreatic cancer. For a disease that has represented some of the darkest corners of oncology for decades, this breakthrough is giving the entire industry renewed hope.
Caris Life Sciences had a monumental presence at ASCO this year, presenting 32 posters along with its Precision Oncology Alliance and Dr. Sledge spotlights one standout abstract in HER2 breast cancer research that has him genuinely energized about what's ahead. For the first time in human history, we have the ability to take a tumor and understand what makes the cancer tick from a wide variety of angles and that changes everything for how we treat the disease long term.
Be sure to like and subscribe to HITea with Grace for honest conversations at the intersection of health, innovation, and technology!